“STUDIES ON FIXED DOSE COMBINATION OF IBRUTINIB AND QUERCETIN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS IN HUMAN CANCER CELL LINES” (2023) International Journal of Pharmaceutical Sciences and Drug Research, 15(6), pp. 764–769. doi:10.25004/IJPSDR.2023.150610.